Wednesday, June 10, 2026

pharma Β· Nonalcoholic Steatohepatitis (NASH) Β· Amyotrophic Lateral Sclerosis Β· CORT

CORCEPT THERAPEUTICS

CORCEPT THERAPEUTICS clinical programs β€” 67 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

101 Redwood Shores Pkwy, Redwood City, California 94065, US HQ
1998 Founded
756 Employees
Public company Type
CORT Β· NYSE Ticker
Company details
Status
Public
HQ
101 Redwood Shores Pkwy, Redwood City, California 94065, US
Founded
1998
Employees
756
Programs
67
Drugs
36
Patents
120
Intelligence Β· Clinical Programs

CORCEPT THERAPEUTICS projects

67 ClinicalTrials.gov programs sponsored by CORCEPT THERAPEUTICS.

CORCEPT THERAPEUTICS has 67 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 2 of 2
  1. Mifepristone and Eribulin in combination

    CORCEPT THERAPEUTICS INC

    Breast Cancer

    phase 1 small molecule completed

    1 trial
  2. Miricorilant

    CORCEPT THERAPEUTICS INC

    Antipsychotic Induced Weight Gain

    phase 1 small molecule completed

    1 trial
  3. Miricorilant

    CORCEPT THERAPEUTICS INC

    Non-alcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial
  4. Miricorilant 150 mg

    CORCEPT THERAPEUTICS INC

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 small molecule completed

    1 trial
  5. Miricorilant 300 mg tablets

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  6. Miricorilant Treatment A

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  7. Olanzapine

    CORCEPT THERAPEUTICS INC

    Antipsychotic-induced Weight Gain

    phase 1 small molecule completed

    1 trial
  8. Relacorilant

    CORCEPT THERAPEUTICS INC

    Adrenocortical Carcinoma

    phase 1 small molecule completed

    1 trial
  9. Relacorilant

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  10. Relacorilant

    CORCEPT THERAPEUTICS INC

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial
  11. Relacorilant (3x100 mg softgel capsules)

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  12. Relacorilant 350mg

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  13. Relacorilant Fasted

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  14. Relacorilant under fasted conditions

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  15. Risperidone

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  16. [14C]-CORT113176

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  17. [14C]-CORT125134

    CORCEPT THERAPEUTICS INC

    Healthy

    phase 1 small molecule completed

    1 trial
  18. mifepristone + fluvastatin

    CORCEPT THERAPEUTICS INC

    Healthy Subjects

    phase 1 small molecule completed

    1 trial
  19. Mifepristone 300 MG [Korlym]

    CORCEPT THERAPEUTICS INC

    Hypercortisolism

    approved small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does CORCEPT THERAPEUTICS have?

67 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.